Memantine to Treat Social Impairment in Youths With Autism Spectrum Disorder: A Randomized Clinical Trial

CONCLUSIONS AND RELEVANCE: In this trial, memantine was well tolerated and significantly improved social impairments in youths with ASD. Elevated pgACC glutamate levels were associated with a favorable treatment response, supporting their potential as a biomarker for assessing memantine efficacy in individuals with ASD.

via https://pubmed.ncbi.nlm.nih.gov/41032298/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1lqZ3NPYysePVKsoyz66mDSgu4veDGJwnUBS47TBQPoOuNZY5J&fc=None&ff=20251013011011&v=2.18.0.post9+e462414